Imaging of malignant lymphomas with F-18FDG coincidence defection positron emission tomography

被引:12
作者
Hwang, K
Park, CH
Kim, HC
Kim, H
Yoon, S
Pai, MS
Kim, S
机构
[1] Ajou Univ, Sch Med, Dept Nucl Med, Suwon 442749, South Korea
[2] Ajou Univ, Sch Med, Dept Hemato Oncol, Suwon 442749, South Korea
关键词
coincidence positron emission tomography; dual-head gamma camera; F-18; fluorodeoxyglucose; lymphoma;
D O I
10.1097/00003072-200010000-00008
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The authors evaluated the utility of F-18 fluorodeoxyglucose (FDG) coincidence detection (CoDe) positron emission tomography (PET) for staging, post-treatment evaluation, and follow-up assessment of patients with malignant lymphomas. Materials and Methods: Fifty-eight patients with histologically proved malignant lymphomas (4 Hodgkin's disease, 54 non-Hodgkin's lymphoma) underwent CoDe PET using F-18 FDG. CoDe PET was performed using a dual-head gamma camera equipped with coincidence detection circuitry. Of the 87 CoDe PET studies, 26 were performed for staging, 38 for post-treatment evaluation, and 23 for follow-up evaluation of recurrence. The entire trunk, from the cervical to the inguinal regions, or selected regions were scanned with the patient in the supine position. No attenuation correction was made and reconstruction was performed using filtered backprojection rather than iterative reconstruction. CoDe PET findings were compared with corresponding results of computed tomographic (CT) and magnetic resonance imaging (MRI), tissue biopsy, or clinical follow-up. Results: For staging, 52 sites were positive on CoDe PET or CT-MRI, CoDe PET detected 49 sites (94%), and CT-MRI showed 47 sites (90%). CoDe PET detected five more lymphomatous lesions and missed three lesions. For post-treatment evaluation, CoDe PET showed a positive predictive value of 100% and a negative predictive value of 83%, but the validated cases numbered only 11. For follow-up for recurrence, CoDe PET had a negative predictive value of 90%, but frequent false-positive findings were noted in the head and neck region as a result of underlying inflammatory changes. Conclusions: For staging, FDG CoDe PET alone without attenuation correction is not sensitive enough to be used as an independent imaging method, especially for small abdominal lesions, However, it appears to be an accurate method for assessing residual disease and for patient follow-up.
引用
收藏
页码:789 / 795
页数:7
相关论文
共 49 条
  • [41] SMITH EM, 1997, J NUCL MED S, V38, P208
  • [42] MALIGNANT-MELANOMA - STAGING WITH WHOLE-BODY POSITRON EMISSION TOMOGRAPHY AND 2-[F-18]-FLUORO-2-DEOXY-D-GLUCOSE
    STEINERT, HC
    BONI, RAH
    BUCK, A
    BONI, R
    BERTHOLD, T
    MARINCEK, B
    BURG, G
    VONSCHULTHESS, GK
    [J]. RADIOLOGY, 1995, 195 (03) : 705 - 709
  • [43] Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling
    Steinert, HC
    Hauser, M
    Allemann, F
    Engel, H
    Berthold, T
    vonSchulthess, GK
    Weder, W
    [J]. RADIOLOGY, 1997, 202 (02) : 441 - 446
  • [44] Stokkel MP, 1998, J NUCL MED, V39, P1385
  • [45] Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography
    Stumpe, KDM
    Urbinelli, M
    Steinert, HC
    Glanzmann, C
    Buck, A
    von Schulthess, GK
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (07) : 721 - 728
  • [46] MAGNETIC-RESONANCE-IMAGING IN THE INITIAL STAGING OF HODGKINS-DISEASE AND NON-HODGKIN LYMPHOMA
    TESOROTESS, JD
    BALZARINI, L
    CEGLIA, E
    PETRILLO, R
    SANTORO, A
    MUSUMECI, R
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 1991, 12 (02) : 81 - 90
  • [47] PERFORMANCE-CHARACTERISTICS OF A 511-KEV COLLIMATOR FOR IMAGING POSITRON EMITTERS WITH A STANDARD GAMMA-CAMERA
    VANLINGEN, A
    HUIJGENS, PC
    VISSER, FC
    OSSENKOPPELE, GJ
    HOEKSTRA, OS
    MARTENS, HJM
    HUITINK, H
    HERSCHEID, KDM
    GREEN, MV
    TEULE, GJJ
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (05): : 315 - 321
  • [48] ZIEGLER SI, 1997, J NUCL MED S, V38, P206
  • [49] Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: effects of non-uniform attenuation correction on lesion detection
    Zimny, M
    Kaiser, HJ
    Cremerius, U
    Reinartz, P
    Schreckenberger, M
    Sabri, O
    Buell, U
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (08) : 818 - 823